Researchers at UWE Bristol have developed a paper-based diagnostic test capable of identifying bleeding and clotting disorders, offering a low-cost alternative to traditional laboratory equipment. According to a study published in Anal Lett, the device uses modified lateral flow technology to analyze blood samples, a development that could expand diagnostic access in regions lacking specialized healthcare infrastructure.
How Paper-Based Diagnostics Could Transform Global Healthcare
The new diagnostic tool functions through “frugal innovation,” utilizing paper strips to determine a patient’s bleeding or clotting status. Professor Tony Killard, lead researcher at UWE Bristol’s Centre for Biomedical Research, described the breakthrough as a successful “long shot” that effectively identifies specific platelet-related markers. By altering lateral flow tests with specific reagents, the team aims to differentiate between various conditions, including Von Willebrand disease and Glanzmann’s Thrombasthenia.
Von Willebrand disease is the most common inherited bleeding disorder, affecting up to one percent of the global population. Current diagnostic methods often require specialized hospital laboratories, which are frequently unavailable in remote or low-resource settings.
What Are the Advantages for Low-Resource Environments?
In regions where hospital access is limited, this technology could provide a critical diagnostic bridge. Professor Killard notes that the project’s design vision involves a “daisy wheel” configuration. This allows a patient to apply a single blood sample to a central zone, which then feeds into multiple flow channels to conduct several tests simultaneously. According to the research team, this approach could allow for the effective, targeted use of low-cost drugs, preventing the administration of harmful treatments for misdiagnosed conditions.
How Will This Impact Clinical Care?
The potential applications extend beyond general diagnosis to specific clinical procedures. Improvements in pre- and post-partum care for women with undiagnosed bleeding disorders represent a primary goal for the research team. Furthermore, the technology could facilitate safer surgical interventions in areas where patients currently undergo procedures without prior diagnostic assessment. The research team recently conducted site visits to The Gambia to discuss the technology’s utility with local healthcare professionals, who provided positive feedback on the concept.
When assessing diagnostic innovation, look for “frugal” solutions that prioritize existing infrastructure—like paper strips—rather than requiring expensive, proprietary hardware that is difficult to maintain in the field.
Frequently Asked Questions
- What conditions can this test identify?
The researchers aim to differentiate thrombocytopenia from disorders like Von Willebrand disease, Bernard Soulier disease, and Glanzmann’s Thrombasthenia. - How does the “daisy wheel” design work?
It uses a central sample application zone with multiple flow channels, allowing several different tests to be performed from a single drop of blood. - Why is this considered “frugal innovation”?
It utilizes low-cost, paper-based lateral flow technology rather than expensive laboratory machinery, making it suitable for regions with limited healthcare resources.
Have questions about the future of point-of-care diagnostics or want to stay updated on our latest health technology reports? Subscribe to our newsletter or leave a comment below to join the conversation.
